From Announcement
The Company is the first organisation to file for a multi drug 510(k) clearance on a saliva
illicit drug testing device and is optimistic subject to FDA review that clearance could be
achieved within the first quarter of calendar year 2008. With no saliva tests having attained
510(k) clearance, the Company views the matter of compliance with FDA guidelines as a
strategic imperative that will provide a significant competitive advantage in the U.S. market.
All available resources are focused on delivering 510(k) clearance in the shortest practical
timeframe.
- Forums
- ASX - By Stock
- HGR
- one of a kind
HGR
unknown
one of a kind, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HGR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online